AAD 2022: Incyte's latest Opzelura data show med's benefit grows over time in vitiligo

siteadmin March 27, 2022

AAD 2022: Incyte’s latest Opzelura data show med’s benefit grows over time in vitiligo
fkansteiner
Sat, 03/26/2022 – 08:37

Source: www.fiercepharma.comRead more